Tropisetron, Ondansetron, and Granisetron for Control of Chemotherapy-Induced Emesis in Turkish Cancer Patients: A Comparison of Efficacy, Side-Effect Profile, and Cost

By Abali Huseyin   Celik Ismail  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 135-139

Informa Healthcare

Access to resources Recommend Favorite

Prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy to moderate or high emetogenic areas: A prospective randomized open label study in cancer patients

By Mystakidou K.   Katsouda E.   Linou A.   Parpa E.   Kouloulias V.   Nikolaou V.   Vlahos L.  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 251-262

Humana Press, Inc

Access to resources Recommend Favorite

Prevention of Delayed Emesis Induced by Moderately Emetogenic Chemotherapy in Patients with Acute Emesis: A Pilot Study with ACTH-Depot Plus Tropisetron

By Santini D.   Vincenzi B.   Fossati C.   D'Angelillo R.M.   Patti G.   Bianco V.   Avvisati G.   Tonini G.  

Medical Oncology, Vol. 18, Iss. 2, 2001-03 ,pp. : 131-135

Humana Press, Inc

Access to resources Recommend Favorite

Exposure–response analysis of pertuzumab in HER2-positive metastatic breast cancer: absence of effect on QTc prolongation and other ECG parameters

By Garg Amit   Li Jing   Clark Emma   Knott Adam   Carrothers Timothy   Marier Jean-François   Cortés Javier   Brewster Michael   Visich Jennifer   Lum Bert  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1133-1141

Springer Publishing Company

Access to resources Recommend Favorite

Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy

By Herrstedt J.   Sigsgaard TC   Nielsen HA   Handberg J.   Langer SW   Ottesen S.   Dombernowsky P.  

Supportive Care in Cancer, Vol. 15, Iss. 4, 2007-04 ,pp. : 417-426

Springer Publishing Company

Access to resources Recommend Favorite